CD8A and breast carcinoma: Similar research data with respect to neoadjuvant therapy have been reported in breast cancer.34 However, little is known whether adjuvant local and/or systemic cancer therapy could influence the outcomes of studies evaluating CD8+ T‐cell infiltration or not.